Gilead Sciences (GILD) Goodwill & Intangibles (2009 - 2026)

Gilead Sciences (GILD) posted Goodwill & Intangibles of $24.7 billion for Q1 2026, down 2.36% quarter-over-quarter from $25.3 billion in Q4 2025, and down 10.74% year-on-year from $27.7 billion in Q1 2025.

Gilead Sciences (GILD) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Goodwill & Intangibles for 18 consecutive years, with $24.7 billion the latest figure, recorded in Q1 2026.

  • Goodwill & Intangibles for Q1 2026 came in at $24.7 billion, down 10.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.7 billion (down 10.74% YoY), and the FY2025 annual result was $25.3 billion, down 10.51% from the prior year.
  • Goodwill & Intangibles was $24.7 billion for Q1 2026 at Gilead Sciences, down from $25.3 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $38.6 billion in Q1 2022 and troughed at $24.7 billion in Q1 2026.
  • Average Goodwill & Intangibles over 5 years is $32.1 billion, with a median of $31.7 billion recorded in 2024.
  • Year-over-year, Goodwill & Intangibles dropped 5.13% in 2023 and retreated 18.71% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $37.2 billion in 2022, then decreased by 6.56% to $34.8 billion in 2023, then declined by 18.71% to $28.3 billion in 2024, then declined by 10.51% to $25.3 billion in 2025, then declined by 2.36% to $24.7 billion in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $24.7 billion in Q1 2026, $25.3 billion in Q4 2025, and $26.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.70 Bn
Dec 31, 2025 25.29 Bn
Sep 30, 2025 26.28 Bn
Jun 30, 2025 26.88 Bn
Mar 31, 2025 27.67 Bn
Dec 31, 2024 28.26 Bn
Sep 30, 2024 28.86 Bn
Jun 30, 2024 31.15 Bn
Mar 31, 2024 31.74 Bn
Dec 31, 2023 34.77 Bn
Sep 30, 2023 35.47 Bn
Jun 30, 2023 36.06 Bn
Mar 31, 2023 36.66 Bn
Dec 31, 2022 37.21 Bn
Sep 30, 2022 37.75 Bn
Jun 30, 2022 38.20 Bn
Mar 31, 2022 38.65 Bn
Dec 31, 2021 41.79 Bn
Sep 30, 2021 42.23 Bn
Jun 30, 2021 42.68 Bn